1,5-Anhydroglucitol Predicts Mortality in Patients with HBV-Related Acute-on-chronic Liver Failure.
Ling-Jian ZhangYalei ZhaoZhongyang XieLanlan XiaoQingqing HuQian LiShima TangJie WangLan-Juan LiPublished in: Journal of clinical and translational hepatology (2022)
Serum 1,5AG levels are a promising predictor of short-term mortality in HBV-ACLF patients. The 1,5AG distribution changed in mice with D-galactosamine/ lipopolysaccharide-induced liver failure.
Keyphrases
- liver failure
- hepatitis b virus
- lipopolysaccharide induced
- end stage renal disease
- inflammatory response
- cardiovascular events
- ejection fraction
- newly diagnosed
- quantum dots
- chronic kidney disease
- risk factors
- prognostic factors
- liver injury
- peritoneal dialysis
- drug induced
- cardiovascular disease
- metabolic syndrome
- skeletal muscle
- coronary artery disease
- acute respiratory distress syndrome